H.R. 3561 118th Congress
PATIENT Act of 2023
- Health
- Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
- Congress.gov ↗
Latest action, Dec 17, 2024: Referred to the Subcommittee on Health.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
88 cosponsors
Sponsored by Rep. McMorris Rodgers, Cathy [R-WA-5] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
42 D · 46 R
- Democrat
- Republican
- Independent
Referred to: House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
7 reports
AMAC ACTION, INC.
SCHOENING STRATEGIES, LLC
7 reports
7 reports
AMERICAN BENEFITS COUNCIL
SPANGLER STRATEGIES LLC
7 reports
AMERICAN BENEFITS COUNCIL OBO ALLIANCE TO FIGHT FOR HEALTH CARE
SPANGLER STRATEGIES LLC
7 reports
7 reports
AMERICAN INVESTMENT COUNCIL
TARPLIN, DOWNS & YOUNG, LLC
7 reports
AMERICAN MEDICAL ASSOCIATION
AVENUE SOLUTIONS
7 reports
7 reports
ARUP LABORATORIES, INC.
VAN SCOYOC ASSOCIATES
7 reports
ASSOCIATION OF AMERICAN MEDICAL COLLEGES
RUBIN HEALTH POLICY CONSULTING, LLC
7 reports
7 reports
7 reports
All 25 of 179 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| 340B HEALTH | 7 | $2.2M | Q4 2023 | Q3 2024 | yes | |
| AMAC ACTION, INC. | SCHOENING STRATEGIES, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICA'S ESSENTIAL HOSPITALS | 7 | $3.4M | Q4 2023 | Q3 2024 | yes | |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 7 | $20.1M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN BENEFITS COUNCIL | SPANGLER STRATEGIES LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| AMERICAN BENEFITS COUNCIL OBO ALLIANCE TO FIGHT FOR HEALTH CARE | SPANGLER STRATEGIES LLC | 7 | $350K | Q4 2023 | Q3 2024 | yes |
| AMERICAN DENTAL ASSOCIATION | 7 | $3.4M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN INVESTMENT COUNCIL | TARPLIN, DOWNS & YOUNG, LLC | 7 | $500K | Q4 2023 | Q3 2024 | yes |
| AMERICAN INVESTMENT COUNCIL F/K/A PEGCC | 7 | $5.1M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN MEDICAL ASSOCIATION | AVENUE SOLUTIONS | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| AMGEN INC | 7 | $20.1M | Q4 2023 | Q3 2024 | yes | |
| ARUP LABORATORIES, INC. | VAN SCOYOC ASSOCIATES | 7 | $210K | Q4 2023 | Q3 2024 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | RUBIN HEALTH POLICY CONSULTING, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| BLUECROSS BLUESHIELD OF TENNESSEE | 7 | $1.8M | Q4 2023 | Q3 2024 | yes | |
| CALIFORNIA HOSPITAL ASSOCIATION | 7 | $2.7M | Q4 2023 | Q3 2024 | yes | |
| CAMBIA HEALTH SOLUTIONS | 7 | $4.4M | Q4 2023 | Q3 2024 | yes | |
| CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES | 7 | $1.3M | Q4 2023 | Q3 2024 | yes | |
| COLLEGE OF AMERICAN PATHOLOGISTS | 7 | $1.1M | Q4 2023 | Q3 2024 | yes | |
| CVS HEALTH (AND SUBSIDIARIES) | 7 | $14.0M | Q4 2023 | Q3 2024 | yes | |
| GSK (FKA GLAXOSMITHKLINE INC.) | 7 | $8.2M | Q4 2023 | Q3 2024 | yes | |
| HIGHMARK INC | 7 | $1.3M | Q4 2023 | Q3 2024 | yes | |
| HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA | 7 | $493K | Q4 2023 | Q3 2024 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | 7 | $340K | Q4 2023 | Q3 2024 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | FORBES-TATE | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| INDIANA UNIVERSITY HEALTH INC | 7 | $790K | Q4 2023 | Q3 2024 | yes |